APO Research
Talk to an analyst

APO RESEARCH · REPORT

Rifaximin for Suspension

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Rifaximin for Suspension Industry Growth and Trends Forecast to 2032

27 December 202595 pages

Choose your research edition.

Industry ResearchRifaximin for Suspension Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Rifaximin for Suspension Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Rifaximin for Suspension Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rifaximin for Suspension Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Rifaximin for Suspension Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Rifaximin for Suspension market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Rifaximin for Suspension is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Rifaximin for Suspension is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Rifaximin for Suspension is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Rifaximin for Suspension include Arlak Biotech, Cista Medicorp, Ikon Remedies, Weefsel Pharma, Nanjing Chengong Pharmaceutical Co., Ltd., Shandong Dayin Marine Biopharmaceutical Co., Ltd., Shanghai Xinya Pharmaceutical Minhang Co., Ltd. and Yangzhou Sanyao Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Rifaximin for Suspension market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Rifaximin for Suspension market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Rifaximin for Suspension market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Rifaximin for Suspension.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Rifaximin for Suspension market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Rifaximin for Suspension Market by Company

Arlak Biotech

Cista Medicorp

Ikon Remedies

Weefsel Pharma

Nanjing Chengong Pharmaceutical Co., Ltd.

Shandong Dayin Marine Biopharmaceutical Co., Ltd.

Shanghai Xinya Pharmaceutical Minhang Co., Ltd.

Yangzhou Sanyao Pharmaceutical Co., Ltd.

Rifaximin for Suspension Segment by Type

0.1g

0.2g

Rifaximin for Suspension Segment by Application

Hospital

Clinic

Other

Rifaximin for Suspension Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rifaximin for Suspension market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rifaximin for Suspension and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rifaximin for Suspension.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Rifaximin for Suspension manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Rifaximin for Suspension in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 0.1g Table 2. Major Company of 0.2g Table 3. Global Rifaximin for Suspension Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Rifaximin for Suspension Sales by Type (2021-2026) & (K Units) Table 5. Global Rifaximin for Suspension Sales Market Share in Volume by Type (2021-2026) Table 6. Global Rifaximin for Suspension Sales by Type (2021-2026) & (US$ Million) Table 7. Global Rifaximin for Suspension Sales Market Share in Value by Type (2021-2026) Table 8. Global Rifaximin for Suspension Price by Type (2021-2026) & (US$/Unit) Table 9. Global Rifaximin for Suspension Sales by Type (2027-2032) & (K Units) Table 10. Global Rifaximin for Suspension Sales Market Share in Volume by Type (2027-2032) Table 11. Global Rifaximin for Suspension Sales by Type (2027-2032) & (US$ Million) Table 12. Global Rifaximin for Suspension Sales Market Share in Value by Type (2027-2032) Table 13. Global Rifaximin for Suspension Price by Type (2027-2032) & (US$/Unit) Table 14. North America Rifaximin for Suspension Sales by Type (2021-2026) & (K Units) Table 15. North America Rifaximin for Suspension Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Rifaximin for Suspension Sales by Type (2021-2026) & (K Units) Table 17. Europe Rifaximin for Suspension Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Rifaximin for Suspension Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Rifaximin for Suspension Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Rifaximin for Suspension Sales by Type (2021-2026) & (K Units) Table 21. Latin America Rifaximin for Suspension Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Rifaximin for Suspension Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Rifaximin for Suspension Sales by Type (2021-2026) & (US$ Million) Table 24. Rifaximin for Suspension Industry Trends Table 25. Rifaximin for Suspension Industry Drivers Table 26. Rifaximin for Suspension Industry Opportunities and Challenges Table 27. Rifaximin for Suspension Industry Restraints Table 28. Global Rifaximin for Suspension Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Rifaximin for Suspension Revenue Market Share by Company (2021-2026) Table 30. Global Rifaximin for Suspension Sales by Company (2021-2026) & (K Units) Table 31. Global Rifaximin for Suspension Sales Share by Company (2021-2026) Table 32. Global Rifaximin for Suspension Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Rifaximin for Suspension Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Rifaximin for Suspension Major Company Production Sites and Headquarters Table 35. Global Rifaximin for Suspension Company, Product Type & Application Table 36. Global Rifaximin for Suspension Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Rifaximin for Suspension by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Rifaximin for Suspension Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Rifaximin for Suspension Sales by Region (2021-2026) & (K Units) Table 41. Global Rifaximin for Suspension Sales Market Share in Volume by Region (2021-2026) Table 42. Global Rifaximin for Suspension Sales by Region (2021-2026) & (US$ Million) Table 43. Global Rifaximin for Suspension Sales Market Share in Value by Region (2021-2026) Table 44. Global Rifaximin for Suspension Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Rifaximin for Suspension Sales by Region (2027-2032) & (K Units) Table 46. Global Rifaximin for Suspension Sales Market Share in Volume by Region (2027-2032) Table 47. Global Rifaximin for Suspension Sales by Region (2027-2032) & (US$ Million) Table 48. Global Rifaximin for Suspension Sales Market Share in Value by Region (2027-2032) Table 49. Global Rifaximin for Suspension Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Rifaximin for Suspension Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Rifaximin for Suspension Sales by Application (2021-2026) & (K Units) Table 52. Global Rifaximin for Suspension Sales Market Share in Volume by Application (2021-2026) Table 53. Global Rifaximin for Suspension Sales by Application (2021-2026) & (US$ Million) Table 54. Global Rifaximin for Suspension Sales Market Share in Value by Application (2021-2026) Table 55. Global Rifaximin for Suspension Price by Application (2021-2026) & (US$/Unit) Table 56. Global Rifaximin for Suspension Sales by Application (2027-2032) & (K Units) Table 57. Global Rifaximin for Suspension Sales Market Share in Volume by Application (2027-2032) Table 58. Global Rifaximin for Suspension Sales by Application (2027-2032) & (US$ Million) Table 59. Global Rifaximin for Suspension Sales Market Share in Value by Application (2027-2032) Table 60. Global Rifaximin for Suspension Price by Application (2027-2032) & (US$/Unit) Table 61. North America Rifaximin for Suspension Sales by Application (2021-2026) & (K Units) Table 62. North America Rifaximin for Suspension Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Rifaximin for Suspension Sales by Application (2021-2026) & (K Units) Table 64. Europe Rifaximin for Suspension Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Rifaximin for Suspension Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Rifaximin for Suspension Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Rifaximin for Suspension Sales by Application (2021-2026) & (K Units) Table 68. Latin America Rifaximin for Suspension Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Rifaximin for Suspension Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Rifaximin for Suspension Sales by Application (2021-2026) & (US$ Million) Table 71. Arlak Biotech Company Information Table 72. Arlak Biotech Business Overview Table 73. Arlak Biotech Rifaximin for Suspension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Arlak Biotech Rifaximin for Suspension Product Portfolio Table 75. Arlak Biotech Recent Development Table 76. Cista Medicorp Company Information Table 77. Cista Medicorp Business Overview Table 78. Cista Medicorp Rifaximin for Suspension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Cista Medicorp Rifaximin for Suspension Product Portfolio Table 80. Cista Medicorp Recent Development Table 81. Ikon Remedies Company Information Table 82. Ikon Remedies Business Overview Table 83. Ikon Remedies Rifaximin for Suspension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Ikon Remedies Rifaximin for Suspension Product Portfolio Table 85. Ikon Remedies Recent Development Table 86. Weefsel Pharma Company Information Table 87. Weefsel Pharma Business Overview Table 88. Weefsel Pharma Rifaximin for Suspension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Weefsel Pharma Rifaximin for Suspension Product Portfolio Table 90. Weefsel Pharma Recent Development Table 91. Nanjing Chengong Pharmaceutical Co., Ltd. Company Information Table 92. Nanjing Chengong Pharmaceutical Co., Ltd. Business Overview Table 93. Nanjing Chengong Pharmaceutical Co., Ltd. Rifaximin for Suspension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Nanjing Chengong Pharmaceutical Co., Ltd. Rifaximin for Suspension Product Portfolio Table 95. Nanjing Chengong Pharmaceutical Co., Ltd. Recent Development Table 96. Shandong Dayin Marine Biopharmaceutical Co., Ltd. Company Information Table 97. Shandong Dayin Marine Biopharmaceutical Co., Ltd. Business Overview Table 98. Shandong Dayin Marine Biopharmaceutical Co., Ltd. Rifaximin for Suspension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Shandong Dayin Marine Biopharmaceutical Co., Ltd. Rifaximin for Suspension Product Portfolio Table 100. Shandong Dayin Marine Biopharmaceutical Co., Ltd. Recent Development Table 101. Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Company Information Table 102. Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Business Overview Table 103. Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Rifaximin for Suspension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Rifaximin for Suspension Product Portfolio Table 105. Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Recent Development Table 106. Yangzhou Sanyao Pharmaceutical Co., Ltd. Company Information Table 107. Yangzhou Sanyao Pharmaceutical Co., Ltd. Business Overview Table 108. Yangzhou Sanyao Pharmaceutical Co., Ltd. Rifaximin for Suspension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Yangzhou Sanyao Pharmaceutical Co., Ltd. Rifaximin for Suspension Product Portfolio Table 110. Yangzhou Sanyao Pharmaceutical Co., Ltd. Recent Development Table 111. North America Rifaximin for Suspension Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. North America Rifaximin for Suspension Sales by Country (2021-2026) & (K Units) Table 113. North America Rifaximin for Suspension Sales Market Share by Country (2021-2026) Table 114. North America Rifaximin for Suspension Sales Forecast by Country (2027-2032) & (K Units) Table 115. North America Rifaximin for Suspension Sales Market Share Forecast by Country (2027-2032) Table 116. North America Rifaximin for Suspension Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. North America Rifaximin for Suspension Market Size by Country (2021-2026) & (US$ Million) Table 118. North America Rifaximin for Suspension Market Share by Country (2021-2026) Table 119. North America Rifaximin for Suspension Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. North America Rifaximin for Suspension Market Share Forecast by Country (2027-2032) Table 121. Europe Rifaximin for Suspension Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Europe Rifaximin for Suspension Sales by Country (2021-2026) & (K Units) Table 123. Europe Rifaximin for Suspension Sales Market Share by Country (2021-2026) Table 124. Europe Rifaximin for Suspension Sales Forecast by Country (2027-2032) & (K Units) Table 125. Europe Rifaximin for Suspension Sales Market Share Forecast by Country (2027-2032) Table 126. Europe Rifaximin for Suspension Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Europe Rifaximin for Suspension Market Size by Country (2021-2026) & (US$ Million) Table 128. Europe Rifaximin for Suspension Market Share by Country (2021-2026) Table 129. Europe Rifaximin for Suspension Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Europe Rifaximin for Suspension Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Rifaximin for Suspension Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Rifaximin for Suspension Sales by Country (2021-2026) & (K Units) Table 133. Asia-Pacific Rifaximin for Suspension Sales Market Share by Country (2021-2026) Table 134. Asia-Pacific Rifaximin for Suspension Sales Forecast by Country (2027-2032) & (K Units) Table 135. Asia-Pacific Rifaximin for Suspension Sales Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Rifaximin for Suspension Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Rifaximin for Suspension Market Size by Country (2021-2026) & (US$ Million) Table 138. Asia-Pacific Rifaximin for Suspension Market Share by Country (2021-2026) Table 139. Asia-Pacific Rifaximin for Suspension Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Asia-Pacific Rifaximin for Suspension Market Share Forecast by Country (2027-2032) Table 141. Latin America Rifaximin for Suspension Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Latin America Rifaximin for Suspension Sales by Country (2021-2026) & (K Units) Table 143. Latin America Rifaximin for Suspension Sales Market Share by Country (2021-2026) Table 144. Latin America Rifaximin for Suspension Sales Forecast by Country (2027-2032) & (K Units) Table 145. Latin America Rifaximin for Suspension Sales Market Share Forecast by Country (2027-2032) Table 146. Latin America Rifaximin for Suspension Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Latin America Rifaximin for Suspension Market Size by Country (2021-2026) & (US$ Million) Table 148. Latin America Rifaximin for Suspension Market Share by Country (2021-2026) Table 149. Latin America Rifaximin for Suspension Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Latin America Rifaximin for Suspension Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Rifaximin for Suspension Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Rifaximin for Suspension Sales by Country (2021-2026) & (K Units) Table 153. Middle East and Africa Rifaximin for Suspension Sales Market Share by Country (2021-2026) Table 154. Middle East and Africa Rifaximin for Suspension Sales Forecast by Country (2027-2032) & (K Units) Table 155. Middle East and Africa Rifaximin for Suspension Sales Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Rifaximin for Suspension Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Rifaximin for Suspension Market Size by Country (2021-2026) & (US$ Million) Table 158. Middle East and Africa Rifaximin for Suspension Market Share by Country (2021-2026) Table 159. Middle East and Africa Rifaximin for Suspension Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Middle East and Africa Rifaximin for Suspension Market Share Forecast by Country (2027-2032) Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. Rifaximin for Suspension Distributors List Table 164. Rifaximin for Suspension Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Rifaximin for Suspension Image Figure 2. Global Rifaximin for Suspension Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rifaximin for Suspension Market Size (2021-2032) & (US$ Million) Figure 4. Global Rifaximin for Suspension Sales (2021-2032) & (K Units) Figure 5. 0.1g Image Figure 6. Global 0.1g Sales YoY Growth (2021-2032) & (K Units) Figure 7. 0.2g Image Figure 8. Global 0.2g Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Rifaximin for Suspension Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Rifaximin for Suspension Market Share by Type 2025 VS 2032 Figure 11. North America Rifaximin for Suspension Sales Market Share in Volume by Type in 2025 Figure 12. North America Rifaximin for Suspension Sales Market Share in Value by Type in 2025 Figure 13. Europe Rifaximin for Suspension Sales Market Share in Volume by Type in 2025 Figure 14. Europe Rifaximin for Suspension Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Rifaximin for Suspension Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Rifaximin for Suspension Sales Market Share in Value by Type in 2025 Figure 17. Latin America Rifaximin for Suspension Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Rifaximin for Suspension Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Rifaximin for Suspension Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Rifaximin for Suspension Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Rifaximin for Suspension Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Rifaximin for Suspension Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Rifaximin for Suspension Market Share by Application 2025 VS 2032 Figure 31. North America Rifaximin for Suspension Sales Market Share in Volume by Application in 2025 Figure 32. North America Rifaximin for Suspension Sales Market Share in Value by Application in 2025 Figure 33. Europe Rifaximin for Suspension Sales Market Share in Volume by Application in 2025 Figure 34. Europe Rifaximin for Suspension Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Rifaximin for Suspension Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Rifaximin for Suspension Sales Market Share in Value by Application in 2025 Figure 37. Latin America Rifaximin for Suspension Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Rifaximin for Suspension Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Rifaximin for Suspension Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Rifaximin for Suspension Sales Market Share in Value by Application in 2025 Figure 41. North America Rifaximin for Suspension Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Rifaximin for Suspension Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Rifaximin for Suspension Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Rifaximin for Suspension Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Rifaximin for Suspension Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Rifaximin for Suspension Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Rifaximin for Suspension Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Rifaximin for Suspension Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Rifaximin for Suspension Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Rifaximin for Suspension Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Rifaximin for Suspension Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Rifaximin for Suspension Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Rifaximin for Suspension Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Rifaximin for Suspension Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Rifaximin for Suspension Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Rifaximin for Suspension Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Rifaximin for Suspension Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Rifaximin for Suspension Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Rifaximin for Suspension Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Rifaximin for Suspension Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Rifaximin for Suspension Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Rifaximin for Suspension Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 0.1g
  • 0.2g
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Arlak Biotech
  • Cista Medicorp
  • Ikon Remedies
  • Weefsel Pharma
  • Nanjing Chengong Pharmaceutical Co., Ltd.
  • Shandong Dayin Marine Biopharmaceutical Co., Ltd.
  • Shanghai Xinya Pharmaceutical Minhang Co., Ltd.
  • Yangzhou Sanyao Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Rifaximin for Suspension Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Rifaximin for Suspension Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Rifaximin for Suspension Market by Type
  6. 1.3.1 0.1g
  7. 1.3.2 0.2g
  8. 1.4 Global Rifaximin for Suspension Market Size by Type
  9. 1.4.1 Global Rifaximin for Suspension Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Rifaximin for Suspension Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Rifaximin for Suspension Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Rifaximin for Suspension Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Rifaximin for Suspension Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Rifaximin for Suspension Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Rifaximin for Suspension Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Rifaximin for Suspension Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Rifaximin for Suspension Industry Trends
  2. 2.2 Rifaximin for Suspension Industry Drivers
  3. 2.3 Rifaximin for Suspension Industry Opportunities and Challenges
  4. 2.4 Rifaximin for Suspension Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Rifaximin for Suspension Revenue (2021-2026)
  2. 3.2 Global Top Players by Rifaximin for Suspension Sales (2021-2026)
  3. 3.3 Global Top Players by Rifaximin for Suspension Price (2021-2026)
  4. 3.4 Global Rifaximin for Suspension Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Rifaximin for Suspension Major Company Production Sites & Headquarters
  6. 3.6 Global Rifaximin for Suspension Company, Product Type & Application
  7. 3.7 Global Rifaximin for Suspension Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Rifaximin for Suspension Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Rifaximin for Suspension Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Rifaximin for Suspension Tier 1, Tier 2, and Tier 3
4 Rifaximin for Suspension Regional Status and Outlook
  1. 4.1 Global Rifaximin for Suspension Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Rifaximin for Suspension Historic Market Size by Region
  3. 4.2.1 Global Rifaximin for Suspension Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Rifaximin for Suspension Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Rifaximin for Suspension Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Rifaximin for Suspension Forecasted Market Size by Region
  7. 4.3.1 Global Rifaximin for Suspension Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Rifaximin for Suspension Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Rifaximin for Suspension Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Rifaximin for Suspension by Application
  1. 5.1 Rifaximin for Suspension Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Rifaximin for Suspension Market Size by Application
  6. 5.2.1 Global Rifaximin for Suspension Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Rifaximin for Suspension Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Rifaximin for Suspension Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Rifaximin for Suspension Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Rifaximin for Suspension Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Rifaximin for Suspension Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Rifaximin for Suspension Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Rifaximin for Suspension Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Arlak Biotech
  2. 6.1.1 Arlak Biotech Company Information
  3. 6.1.2 Arlak Biotech Business Overview
  4. 6.1.3 Arlak Biotech Rifaximin for Suspension Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Arlak Biotech Rifaximin for Suspension Product Portfolio
  6. 6.1.5 Arlak Biotech Recent Developments
  7. 6.2 Cista Medicorp
  8. 6.2.1 Cista Medicorp Company Information
  9. 6.2.2 Cista Medicorp Business Overview
  10. 6.2.3 Cista Medicorp Rifaximin for Suspension Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Cista Medicorp Rifaximin for Suspension Product Portfolio
  12. 6.2.5 Cista Medicorp Recent Developments
  13. 6.3 Ikon Remedies
  14. 6.3.1 Ikon Remedies Company Information
  15. 6.3.2 Ikon Remedies Business Overview
  16. 6.3.3 Ikon Remedies Rifaximin for Suspension Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Ikon Remedies Rifaximin for Suspension Product Portfolio
  18. 6.3.5 Ikon Remedies Recent Developments
  19. 6.4 Weefsel Pharma
  20. 6.4.1 Weefsel Pharma Company Information
  21. 6.4.2 Weefsel Pharma Business Overview
  22. 6.4.3 Weefsel Pharma Rifaximin for Suspension Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Weefsel Pharma Rifaximin for Suspension Product Portfolio
  24. 6.4.5 Weefsel Pharma Recent Developments
  25. 6.5 Nanjing Chengong Pharmaceutical Co., Ltd.
  26. 6.5.1 Nanjing Chengong Pharmaceutical Co., Ltd. Company Information
  27. 6.5.2 Nanjing Chengong Pharmaceutical Co., Ltd. Business Overview
  28. 6.5.3 Nanjing Chengong Pharmaceutical Co., Ltd. Rifaximin for Suspension Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Nanjing Chengong Pharmaceutical Co., Ltd. Rifaximin for Suspension Product Portfolio
  30. 6.5.5 Nanjing Chengong Pharmaceutical Co., Ltd. Recent Developments
  31. 6.6 Shandong Dayin Marine Biopharmaceutical Co., Ltd.
  32. 6.6.1 Shandong Dayin Marine Biopharmaceutical Co., Ltd. Company Information
  33. 6.6.2 Shandong Dayin Marine Biopharmaceutical Co., Ltd. Business Overview
  34. 6.6.3 Shandong Dayin Marine Biopharmaceutical Co., Ltd. Rifaximin for Suspension Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Shandong Dayin Marine Biopharmaceutical Co., Ltd. Rifaximin for Suspension Product Portfolio
  36. 6.6.5 Shandong Dayin Marine Biopharmaceutical Co., Ltd. Recent Developments
  37. 6.7 Shanghai Xinya Pharmaceutical Minhang Co., Ltd.
  38. 6.7.1 Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Company Information
  39. 6.7.2 Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Business Overview
  40. 6.7.3 Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Rifaximin for Suspension Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Rifaximin for Suspension Product Portfolio
  42. 6.7.5 Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Recent Developments
  43. 6.8 Yangzhou Sanyao Pharmaceutical Co., Ltd.
  44. 6.8.1 Yangzhou Sanyao Pharmaceutical Co., Ltd. Company Information
  45. 6.8.2 Yangzhou Sanyao Pharmaceutical Co., Ltd. Business Overview
  46. 6.8.3 Yangzhou Sanyao Pharmaceutical Co., Ltd. Rifaximin for Suspension Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Yangzhou Sanyao Pharmaceutical Co., Ltd. Rifaximin for Suspension Product Portfolio
  48. 6.8.5 Yangzhou Sanyao Pharmaceutical Co., Ltd. Recent Developments
7 North America by Country
  1. 7.1 North America Rifaximin for Suspension Sales by Country
  2. 7.1.1 North America Rifaximin for Suspension Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Rifaximin for Suspension Sales by Country (2021-2026)
  4. 7.1.3 North America Rifaximin for Suspension Sales Forecast by Country (2027-2032)
  5. 7.2 North America Rifaximin for Suspension Market Size by Country
  6. 7.2.1 North America Rifaximin for Suspension Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Rifaximin for Suspension Market Size by Country (2021-2026)
  8. 7.2.3 North America Rifaximin for Suspension Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Rifaximin for Suspension Sales by Country
  2. 8.1.1 Europe Rifaximin for Suspension Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Rifaximin for Suspension Sales by Country (2021-2026)
  4. 8.1.3 Europe Rifaximin for Suspension Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Rifaximin for Suspension Market Size by Country
  6. 8.2.1 Europe Rifaximin for Suspension Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Rifaximin for Suspension Market Size by Country (2021-2026)
  8. 8.2.3 Europe Rifaximin for Suspension Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Rifaximin for Suspension Sales by Country
  2. 9.1.1 Asia-Pacific Rifaximin for Suspension Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Rifaximin for Suspension Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Rifaximin for Suspension Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Rifaximin for Suspension Market Size by Country
  6. 9.2.1 Asia-Pacific Rifaximin for Suspension Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Rifaximin for Suspension Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Rifaximin for Suspension Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Rifaximin for Suspension Sales by Country
  2. 10.1.1 South America Rifaximin for Suspension Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Rifaximin for Suspension Sales by Country (2021-2026)
  4. 10.1.3 South America Rifaximin for Suspension Sales Forecast by Country (2027-2032)
  5. 10.2 South America Rifaximin for Suspension Market Size by Country
  6. 10.2.1 South America Rifaximin for Suspension Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Rifaximin for Suspension Market Size by Country (2021-2026)
  8. 10.2.3 South America Rifaximin for Suspension Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Rifaximin for Suspension Sales by Country
  2. 11.1.1 Middle East and Africa Rifaximin for Suspension Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Rifaximin for Suspension Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Rifaximin for Suspension Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Rifaximin for Suspension Market Size by Country
  6. 11.2.1 Middle East and Africa Rifaximin for Suspension Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Rifaximin for Suspension Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Rifaximin for Suspension Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Rifaximin for Suspension Value Chain Analysis
  2. 12.1.1 Rifaximin for Suspension Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Rifaximin for Suspension Production Mode & Process
  7. 12.2 Rifaximin for Suspension Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Rifaximin for Suspension Distributors
  10. 12.2.3 Rifaximin for Suspension Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst